Community/Retail

Implementing PrEP in retail community pharmacies increases patient accessibility but may be difficult to incorporate without modifying workflow.

Pharmacies need to differentiate themselves through faster and cheaper care, while delivering health outcomes across the patient journey.

Thought-provoking economic, ethical conundrums accompany recent explosion in growth of glucagon-like peptide-1 products for medically assisted weight loss

On March 1, 2023, Eli Lilly and Company said it would take steps to cap insulin prices, and Novo Nordisk and Sanofi followed suit 2 weeks later.

Fomepizole, an FDA-approved drug to treat methanol poisoning, and erythromycin could offer a novel therapeutic option to fight drug-resistant S. pneumoniae.

Investigators suggest that sleep interventions may help to reduce the risk of self-harm in female adolescents with depression and anxiety.

Pharmacists respond to questions about supplementation and and smoking cessation for heart health.

Pharmacists respond to questions about birth control.

Asian Americans often develop the disease at a normal weight, which would be overlooked by current screening guidelines, investigators say.

CGM devices can also help individuals with diabetes make more informed decisions about their diet, exercise, and medication management, leading to improved overall health outcomes.

Legal expert breaks down the history of power between federal v. state law and why Dobbs v. Jackson has caused such a stir for the pharmaceutical community.

The company announced the initiation of the EVERGREEN study, which was aimed to evaluate the efficacy, safety, and immunogenicity of the investigational respiratory syncytial virus vaccine, in 2021.

Products include an as needed treatment for bronchoconstriction and a treatment for Alzheimer disease.

Pharmacists need food too, you know.

This month's guest is Jennifer Lind, PharmD, MPH, MBA, a public health pharmacists, epidemiologist in the Medication Safety Program at the CDC, and commander in the United States Public Health Service Commissioned Corps.

Barbara Kirkaldy, BS, CPhT, pharmacy regulatory specialist at Novant Health, discusses her role in the pharmacy and alternative career paths for pharmacy technicians.

Authorized for use in professional point-of-care settings, the nucleic acid amplification diagnostic tool delivers results in 25 minutes.

Regeneron and Sanofi’s Dupilumab is the first biologic to demonstrate a clinically meaningful and statistically significant reduction in exacerbations compared with the placebo.

Studies show that patients who are introduced to patient support programs through digital platforms are more likely to use support services.

Products include multivitamin gummies and a superfood supplement.

Eflapegrastim-xnst subcutaneous injection (Rolvedon) reduces infections related to febrile neutropenia in adults with nonmyeloid malignant tumors who are being treated with certain anticancer drugs.

FDA action allows for OTC naloxone (Narcan) to be sold directly to consumers in pharmacies, convenience stores, grocery stores, gas stations, and online.

Increased risk for severe disease in individuals with SUD could be from co-occurring medical conditions, investigators from Boston Medical Center say.

Muneeb Shah, DO, dermatologist and partner at PC Dermatology PLLC, and Reid Maclellan, MD, founder of Cortina Health Inc also discuss the role technology and social media play in health care education.

Data indicated that waist-to-height ratio is a better indicator of outcomes in patients with HF than body mass index.

Removing the word ‘risk’ from discussions of HIV PrEP and focusing more on environment and empowerment concerns are beneficial in this patient population.

There has not yet been established a consensus on the set of factors to use for assessing social determinants of health in practice.

Any living person with HIV should be screened for hepatitis B and C upon diagnosis, with annual screenings recommended for those with additional risk factors.

Products include a new NSAID and an oral solution for depression.

Given the promising results, the company is advancing Rinvoq to a phase 3 clinical trial for the autoimmune disorder.